NIH-funded research NIH-funded research

Preventing cervical cancer in women living with HIV in central Kenya

Official title: KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH

Funded at Kenya Medical Research Institute (Kemri) · NIH-11118696 · Data updated 2026-11-12

Offers screening and same-day treatment to help prevent cervical cancer in women living with HIV at local clinics in central Kenya.

More Cervical Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKenya Medical Research Institute (Kemri)
NIH-funded
Lab location1 site (Nairobi City, Kenya)
Project startSeptember 19, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$172,013
NIH project number5UG1CA285132-03
Project IDNIH-11118696 on NIH RePORTER

Who could benefit from this research

Could help

Women living with HIV who receive care at the participating public hospitals in Kiambu County (Thika, Ruiru, Igegania) and are eligible for cervical cancer screening.

Less likely to help

Women not living with HIV, not receiving care at the listed clinics, already diagnosed with invasive cervical cancer, or with medical reasons preventing screening or thermal ablation may not benefit from this program.

What this research studies

If you are a woman living with HIV and attend care at the participating clinics, you may be offered cervical cancer screening as part of your routine visits. The clinics use a screen-and-treat approach where abnormal findings can often be treated the same day using a thermal ablation device. The work is run by KEMRI in partnership with local HIV programs and builds on an ongoing implementation effort called TIBA. Participation may include the screening procedure, a brief outpatient treatment if needed, and follow-up visits.

Why it matters

Potential benefit: This could reduce cervical cancer cases and deaths by finding and treating precancer early among women living with HIV.

How similar studies have gone: Screen-and-treat approaches with single-visit thermal ablation have shown promise in similar low-resource settings and are being used in related projects like the TIBA implementation study.

Where this research is happening

  • Kenya Medical Research Institute (Kemri)
    Nairobi City, Kenya
    Active

Researchers

  • Principal investigator: Mugo, Nelly Rwamba — Kenya Medical Research Institute (Kemri)
  • Study coordinator: Mugo, Nelly Rwamba

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.